The usefulness of a dermocosmetic containing Myrtus communis extract and azelaic acid for maintenance phase of adult female acne: Results from a randomized exploratory investigator-blinded comparative study

E. Bagatin, M.D. Thouvenin, A. Bacquey, S. Baradat, C. Lauze, V. Mengeaud, J.L.M. Soares, L. de S.M. Andrade, H.A. Miot, M.A. Rocha

Journal of European Academy of Dermatology and Venereology

2023

Descubre nuestra infografía

Interest & efficacy of Two Plant Extract Active Ingredients, Myrtacine® & Celastrol.pdf
.PDF 0.51 Mo

Acné

Change in Cutibacterium acnes phylotype abundance and improvement of clinical parameters using a new dermocosmetic product containing Myrtus communis and Celastrol enriched plant cell culture extracts in patients with acne vulgaris

DUCRAY

C. Mias, M.D. Thouvenin, E. Gravier, S. Dalmon, K. Bouyer, S. Alvarez, V. Mengeaud, V. Ribet, S. Bessou-Touya, H. Duplan

Journal of European Academy of Dermatology and Venereology

2023

Ver la publicación

Acné
Pediatría

Recent advances in understanding inflammatory acne: Deciphering the relationship between Cutibacterium acnes and Th17 inflammatory pathway

DUCRAY

C. Mias, V. Mengeaud, S. Bessou-Touya, H. Duplan

Journal of European Academy of Dermatology and Venereology

2023

Ver la publicación

Acné
Pediatría

Myrtus communis and Celastrol enriched plant cell culture extracts control together the pivotal role of Cutibacterium acnes and inflammatory pathways in acne

DUCRAY

C. Mias, N. Chansard, M. Maitre, M.F. Galliano, L. Garidou, V. Mengeaud, S. Bessou-Touya, H. Duplan

Journal of European Academy of Dermatology and Venereology

2023

Ver la publicación

Resumen de la publicación

The usefulness of a dermocosmetic containing Myrtus communis extract and azelaic acid for maintenance phase of adult female acne: Results from a randomized exploratory investigator-blinded comparative study

Descubre nuestra infografía

Interest & efficacy of Two Plant Extract Active Ingredients, Myrtacine® & Celastrol.pdf

Más publicaciones sobre este tema

¿Quiere seguir leyendo?

¿Quiere seguir leyendo?